ScanSource (SCSC) Q1 2027 Earnings Call Transcript

ScanSource (SCSC) reported Q1 2027 net sales growth of 30% YoY, with net profit up 9% YoY. Despite lower margins from large hardware deals and bad debt reserves in Brazil, the company raised its full-year outlook, including contributions from MicroAge. Non-GAAP EPS was $0.86, and free cash flow was negative $44 million. The company expects positive free cash flow for the full fiscal year and plans to continue share repurchases and debt reduction.

Original reporting
Published Nov 5, 2026, 10:50 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 10:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ScanSource (SCSC) Q1 2027 Earnings Call Transcript — source image
Decision brief

The 30-second read

$SCSCBullishHigh
01

Why it matters

Guidance lift could trigger a short‑term rally; investors will watch margin trends and Brazil exposure.

02

Market read

Earnings guidance upgrade for a mid‑cap distributor with notable revenue growth; likely influences sector sentiment.

03

What to watch

Higher working capital needs and Brazil credit risk could constrain cash flow despite guidance.

Relevance 8/10Novelty 8/10Timing: post‑earnings today

Background

ScanSource (SCSC) reported Q1 results and raised FY27 outlook after acquiring MicroAge.

Company-level read

Ticker impact

$SCSCBullishHigh confidence
Context

Q1 2027 earnings call disclosed 30% YoY sales growth, raised full-year sales outlook to $3.8‑$4B and EBITDA to $175‑$185M.

Expected impact

potential upside as market prices in higher sales and EBITDA outlook

Evidence & confidence

Guidance exceeds prior expectations for a mid‑cap distributor; earnings beat and positive free cash flow outlook drive bullish bias.

Market effects

Positive signal for IT distribution and value‑added reseller sector, may lift peers.

U.S. technology distribution segment could see modest gains.

Limited to North American and European distributors; no broad macro effect.

Counterpoint

Guidance may be optimistic given margin pressure from large hardware deals and Brazil bad‑debt exposure.

Key entities

  • MicroAge

    Recent acquisition contributing to revenue growth.

  • Oi SA

    Brazil telecom client prompting bad‑debt reserve.

Related articles

$SCSCMed

ScanSource CEO: MicroAge Will Expand Partner Services, Minimize Channel Conflict

ScanSource CEO Mike Baur discussed the company's $220.5M MicroAge acquisition, aiming to expand partner services while minimizing conflicts. Q1 2027 revenue rose, but earnings fell due to lower-margin Cisco sales and bad debt from a Brazilian customer. Baur expects improved margins and growth in coming quarters, with updated annual guidance reflecting MicroAge's impact.

$SCSCMedAI 8/10

ScanSource Inc (SCSC) Q1 2027 Earnings Call Highlights: 30% Sales Surge, Raised Outlook

ScanSource Inc (SCSC) reported a 30% sales surge in Q1 2027, raising its full-year outlook. Profitability was impacted by lower-margin large hardware deals and bad debt reserves in Brazil. Free cash flow was negative at $44 million but is expected to be positive for the year. The company sees growth opportunities from the MicroAge acquisition and potential market share gains due to TD SYNNEX's acquisition of BlueStar.

$SCSCMed

ScanSource Q1 Earnings Call Highlights

ScanSource (SCSC) reported Q1 net sales up 28% YoY in Specialty Tech Solutions, with gross profit rising 3% to $87M. Margins were pressured by large hardware deals. Brazil sales fell over 20%, with reserves taken on customer Oi S.A. The Intelisys & Solution Services segment saw net sales rise 86% (3.2% organic), with gross profit up 29% to $30M. SCSC expects positive free cash flow for the year, plans debt reduction and share repurchases.